Skip to main content
. 2013 Jul 26;8(7):e69911. doi: 10.1371/journal.pone.0069911

Figure 6. DHR activates p38 MAP kinase but suppresses JNK kinase in human plasma cells.

Figure 6

LP1 and OPM2 cells were treated with DHR at indicated concentrations followed by immunoblotting analyses for p38 (A) and JNK (B) against specific antibodies. GAPDH was used as an internal loading control.